EU
OMass Therapeutics
OMass Therapeutics is a biotechnology company developing small-molecule therapeutics for rare diseases and immunological conditions using its OdyssION platform.
omass.com
1
vacantes activas
Ver todas las vacantes de la empresa
Híbrido 1
Sobre la empresa
OMass Therapeutics is a biotechnology company developing small-molecule therapeutics. Its work focuses on rare diseases and immunological conditions, with programmes aimed at targets such as membrane proteins, intracellular complexes, solute carriers and GPCRs. The company describes its OdyssION platform as combining novel biochemistry, native mass spectrometry and custom chemistry.
Puntos para candidatos
- Biotechnology company developing small-molecule therapeutics.
- Focuses on rare diseases and immunological conditions.
- Uses the OdyssION technology platform for drug discovery.
- Sector económico
- Biotechnology
- Enfoque comercial
- Drug discovery and development of small-molecule therapeutics
- Sede
- Oxford
Vacantes actuales
1
vacantes activas
- Ciudades principales
- Oxford (1)
- Modalidad
- Híbrido (1)
- Contrato
- Jornada completa (1)